Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1978-08-08
1980-04-29
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
424274, A61K 3162, A61K 31405
Patent
active
042006317
ABSTRACT:
Ulcer production in animals is prevented during prolonged antiphlogistic treatment with ulcerogenic quantities of indomethacin by using it in a composition of 1 part of indomethacin to 7.5 to 25 parts, preferably 10 parts by weight of a salicylate. Indomethacin is the most potent ulcerating compound among approved non-steroid antiinflammatory agents.
REFERENCES:
Hultmark et al.-Chem. Abst. vol. 83 (1975), p. 141,706k.
Gietka et al.-Chem. Abst. vol. 82 (1975), p. 291p.
Cholnoky Eszter
Ezer Elemer
Forgach Lilla
Gidai Katalin
Hajos Gyorgy
Richter Gedeon Vegyeszeti Gyar Rt.
Rosen Sam
Ross Karl F.
LandOfFree
Treating mammalian subject sensitive to indomethacin ulcerogenis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating mammalian subject sensitive to indomethacin ulcerogenis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating mammalian subject sensitive to indomethacin ulcerogenis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1684004